The significant role of the BRCA2 p.K3326* in susceptibility to ESCC among the studied population was previously reported by our team (OR = 3.64, 95% CI = 1.74–7.59, P = 0.0004) [26]. This evidence concerns the gene BRCA2 and esophageal squamous cell carcinoma.